Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The myelodysplastic syndromes: diagnosis, molecular biology and risk assessment.

Hematology (Amsterdam, Netherlands) - 1 Jan 2005

Bennett John M, Komrokji Rami S

Abstract excerpt

Myelodysplastic syndromes (MDS) are heterogeneous group of neoplastic clonal stem cell diseases characterized by dysplastic morphological features and clinical bone marrow failure. The FAB (French-American-British) system served as the gold standard for MDS classification for more than two decades. The WHO classification, built on the backbone of FAB classification, is an attempt to further improve the prognostic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apoptosis
Share to Cytogenetic Analysis
Share to Gene Expression Profiling

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Myelodysplastic Syndromes

Share to World Health Organization

Source

Identifiers

PMID: 16188686
DOI: 10.1080/10245330512331390311

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The myelodysplastic syndromes: diagnosis, molecular biology and risk assessment.PMID 16188686Read ↗

Myelodysplastic syndromes classification and risk stratification.Semantic proximity Read ↗

Myelodysplastic syndromes: recent advancements in risk stratification and unmet therapeutic challenges.Semantic proximity Read ↗

Myelodysplastic Syndrome Updated.Semantic proximity Read ↗

Diagnostics and Prognostication of Myelodysplastic SyndromesSemantic proximity Read ↗

Myelodysplastic Syndromes, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.Semantic proximity Read ↗

Reclassifying myelodysplastic syndromes: what's where in the new WHO and why.Semantic proximity Read ↗

[New insights into the nature and classification of myelodysplastic neopmasm].Semantic proximity Read ↗

The Molecular Pathology of Myelodysplastic Syndrome.Semantic proximity Read ↗

Diagnosis and classification of myelodysplastic syndromesSemantic proximity Read ↗

Updates in Risk Stratification in Myelodysplastic Syndromes.Semantic proximity Read ↗

Clinico-genetic and prognostic analyses of 716 patients with primary myelodysplastic syndrome and myelodysplastic syndrome/acute myeloid leukemia based on the 2022 International Consensus Classification.Semantic proximity Read ↗

Epidemiology and Pathogenesis of Myelodysplastic Syndrome.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.